Developer docs
API playgroundTry for free, no card

Search company profiles

IonOpticks

Full company profile

uuid0009m63

Namestring
IonOpticks
Legal namestring
Ion Opticks Pty Ltd
Websiteurl
ionopticks.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

IonOpticks (legal entity: Ion Opticks Pty Ltd) is an Australian life-science tools company founded in 2017 and headquartered in Melbourne. The company develops, manufactures, and distributes liquid chromatography (LC) columns and consumables designed for integration with mass spectrometry (MS) systems used in proteomics and metabolomics research workflows. Its core technical offering is specialized LC front-end hardware positioned to deliver sensitivity and reproducibility gains within nano- and micro-flow LC-MS pipelines used by omics researchers.

The company's commercial strategy centers on becoming the de facto front-end LC partner inside major MS instrument ecosystems. It has established core integration partnerships with SCIEX (a Danaher company) for the ZenoTOF MS platform and with Evosep for low-flow proteomics workflows, and in October 2024 entered a strategic partnership with Danaher Corporation that extends its reach into Danaher's global distribution and service network. Its primary customer segments are life-science researchers conducting proteomics and metabolomics studies, with a secondary segment in pharmaceutical and biotechnology companies requiring mission-critical analytical infrastructure for drug development.

IonOpticks generates revenue through hardware sales of LC columns and consumables, distributed via a direct enterprise sales motion. In February 2026 it created a Chief Commercial Officer role — filled by Darren Sher, formerly of Revvity, Oxford Immunotec, and Siemens Healthineers — to lead global commercial strategy and execute international scaling across sales, marketing, and customer support. The firm operates as a privately held Pty Ltd with no disclosed funding rounds, revenue figures, or external investors in the available source material, and its marketed footprint is concentrated in academic and industrial proteomics research markets globally.

Short descriptiontext

IonOpticks is an Australian life-science tools company that develops and manufactures specialized liquid chromatography columns and consumables for proteomics and metabolomics mass spectrometry workflows, serving academic researchers and pharmaceutical/biotech labs via platform integrations with SCIEX (Danaher) and Evosep.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCollingwood, Australia
HQ citystring
Collingwood
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
liquid chromatography columns, mass spectrometry consumables, proteomics research tools, metabolomics analytical solutions, LC-MS workflow products
Industry2 codes
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Proteomics Tools
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Liquid Chromatography Solutions
TypeHardware Sales
Description

IonOpticks generates revenue through the sale of liquid chromatography solutions, providing analytical technologies for life science research applications in proteomics and metabolomics workflows.

mass-spec-capital.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

IonOpticks develops, manufactures, and distributes liquid chromatography columns and consumables designed to integrate with mass spectrometry systems used in proteomics and metabolomics research workflows. The company's products serve as front-end LC solutions that connect with platforms such as the SCIEX ZenoTOF and Evosep systems, enabling end-to-end analytical workflows for omics researchers and pharmaceutical/biotech organizations.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Liquid Chromatography Solutions (columns and consumables)
CategoryProteomics / Analytical Lab Consumables
Description

Physical LC columns and consumables engineered as front-end solutions for mass spectrometry systems used in proteomics and metabolomics research workflows. Designed for life science researchers, pharmaceutical R&D, and biotech organizations requiring integrated LC-MS analytical infrastructure.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-01
Description

IonOpticks provides integration solutions and source enhancements for the SCIEX ZenoTOF mass spectrometry line at ASMS, creating a connected end-to-end solution for proteomics and metabolomics researchers alongside Evosep integration.

2Evosep
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-01
Description

IonOpticks offers source enhancements for Evosep integration within the SCIEX ZenoTOF platform ecosystem, delivering integrated end-to-end solutions for omics researchers as part of a connected platform approach.

stocktitan.net
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

Danaher Corporation partnered with IonOpticks in October 2024 as part of a broader industry consolidation trend in the life science tools sector. This partnership provides IonOpticks access to Danaher's extensive distribution network and platform ecosystem.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IonOpticks

Proteomics Toolsionopticks.com

IonOpticks is an Australian life-science tools company that develops and manufactures specialized liquid chromatography columns and consumables for proteomics and metabolomics mass spectrometry workflows, serving academic researchers and pharmaceutical/biotech labs via platform integrations with SCIEX (Danaher) and Evosep.

What IonOpticks does

IonOpticks (legal entity: Ion Opticks Pty Ltd) is an Australian life-science tools company founded in 2017 and headquartered in Melbourne. The company develops, manufactures, and distributes liquid chromatography (LC) columns and consumables designed for integration with mass spectrometry (MS) systems used in proteomics and metabolomics research workflows. Its core technical offering is specialized LC front-end hardware positioned to deliver sensitivity and reproducibility gains within nano- and micro-flow LC-MS pipelines used by omics researchers.

The company's commercial strategy centers on becoming the de facto front-end LC partner inside major MS instrument ecosystems. It has established core integration partnerships with SCIEX (a Danaher company) for the ZenoTOF MS platform and with Evosep for low-flow proteomics workflows, and in October 2024 entered a strategic partnership with Danaher Corporation that extends its reach into Danaher's global distribution and service network. Its primary customer segments are life-science researchers conducting proteomics and metabolomics studies, with a secondary segment in pharmaceutical and biotechnology companies requiring mission-critical analytical infrastructure for drug development.

IonOpticks generates revenue through hardware sales of LC columns and consumables, distributed via a direct enterprise sales motion. In February 2026 it created a Chief Commercial Officer role — filled by Darren Sher, formerly of Revvity, Oxford Immunotec, and Siemens Healthineers — to lead global commercial strategy and execute international scaling across sales, marketing, and customer support. The firm operates as a privately held Pty Ltd with no disclosed funding rounds, revenue figures, or external investors in the available source material, and its marketed footprint is concentrated in academic and industrial proteomics research markets globally.

IonOpticks firmographics

Firmographics
Name
IonOpticks
Legal name
Ion Opticks Pty Ltd
Website
https://ionopticks.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
IonOpticks is an Australian life-science tools company that develops and manufactures specialized liquid chromatography columns and consumables for proteomics and metabolomics mass spectrometry workflows, serving academic researchers and pharmaceutical/biotech labs via platform integrations with SCIEX (Danaher) and Evosep.
Ownership category
akta.pro rank

IonOpticks industry classification

Industry
Product category
Proteomics Tools
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)

Keywords

  • Liquid chromatography columns
  • Mass spectrometry consumables
  • Proteomics research tools
  • Metabolomics analytical solutions
  • LC-MS workflow products

Where IonOpticks is headquartered

Location

Headquarters

HQ city
Collingwood
HQ country
Australia
HQ region
Oceania

Markets served

IonOpticks business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Liquid Chromatography Solutions: IonOpticks generates revenue through the sale of liquid chromatography solutions, providing analytical technologies for life science research applications in proteomics and metabolomics workflows.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

IonOpticks product offering

Product offering

Core offering

IonOpticks develops, manufactures, and distributes liquid chromatography columns and consumables designed to integrate with mass spectrometry systems used in proteomics and metabolomics research workflows. The company's products serve as front-end LC solutions that connect with platforms such as the SCIEX ZenoTOF and Evosep systems, enabling end-to-end analytical workflows for omics researchers and pharmaceutical/biotech organizations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Liquid Chromatography Solutions (columns and consumables) Physical LC columns and consumables engineered as front-end solutions for mass spectrometry systems used in proteomics and metabolomics research workflows. Designed for life science researchers, pharmaceutical R&D, and biotech organizations requiring integrated LC-MS analytical infrastructure.

Companies that use IonOpticks

Customer profile

Segments2 records

Ideal customer profiles2 records

IonOpticks technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

IonOpticks partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SCIEX (Danaher Company)coreTechnology or Integration · 1 June 2026IonOpticks provides integration solutions and source enhancements for the SCIEX ZenoTOF mass spectrometry line at ASMS, creating a connected end-to-end solution for proteomics and metabolomics researchers alongside Evosep integration.
  • EvosepcoreTechnology or Integration · 1 June 2026IonOpticks offers source enhancements for Evosep integration within the SCIEX ZenoTOF platform ecosystem, delivering integrated end-to-end solutions for omics researchers as part of a connected platform approach.
  • Danaher CorporationcoreStrategic or Co-development Partner · 1 October 2024Danaher Corporation partnered with IonOpticks in October 2024 as part of a broader industry consolidation trend in the life science tools sector. This partnership provides IonOpticks access to Danaher's extensive distribution network and platform ecosystem.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

IonOpticks competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

IonOpticks social profiles

Digital presence

IonOpticks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IonOpticks leadership team

Management profile

Number of profiles

Profiles2 records

IonOpticks funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IonOpticks M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IonOpticks

What does IonOpticks do?

IonOpticks develops, manufactures, and distributes liquid chromatography columns and consumables designed to integrate with mass spectrometry systems used in proteomics and metabolomics research workflows. The company's products serve as front-end LC solutions that connect with platforms such as the SCIEX ZenoTOF and Evosep systems, enabling end-to-end analytical workflows for omics researchers and pharmaceutical/biotech organizations.

Is IonOpticks a public or private company?

IonOpticks is a private company. It is classified as unknown and is currently operating.

When was IonOpticks founded?

IonOpticks was founded in 2017. It employs 51 to 100 people.

Where is IonOpticks based?

IonOpticks is headquartered in Collingwood, Australia, in the Oceania region.

How does IonOpticks make money?

One revenue line is on record: liquid Chromatography Solutions.

Does IonOpticks have an API?

No public API is recorded for IonOpticks.

What industry is IonOpticks in?

IonOpticks's product category is Proteomics Tools. Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments, with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACIonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.IonOpticks launched Aurora Series 5 with CoreJet integrated emitter and redesigned nanoZero union, claiming over 10,000 protein identifications across 1,400 injections. The upgrade aims to make high-performance nanoflow chromatography routine for proteomics, with Series 5 available from September 15, 2026.PR NewswireIonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.IonOpticks launched Aurora Series 5 with CoreJet integrated emitter and redesigned nanoZero union, claiming over 10,000 protein identifications across 1,400 injections. The upgrade aims to make high-performance nanoflow chromatography routine for proteomics, with Series 5 available from September 15, 2026.MorningstarIonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.IonOpticks launched Aurora Series 5 with CoreJet integrated emitter and redesigned nanoZero union, aiming to boost robustness for routine proteomics. Testing on a Thermo Scientific Vanquish Neo and Orbitrap Astral Zoom sustained over 10,000 unique protein identifications across more than 1,000 injections with no backpressure rise beyond 1,400 runs. The product is available from 15 September 2026.The Mass Spectrometry Web PortalIon Opticks Pty Ltd.. (7/23/26). "Press Release: IonOpticks Opens UK-based Facility to Bring Faster Access, Local Expertise and Application Support Closer to European Researchers". Melbourne & Milton.IonOpticks opened a new UK facility in Milton Park, Oxfordshire, to support European researchers with faster access and local expertise. The facility includes order processing, warehousing, and an applications development lab, and introduces Dr Anuar Makhmut as Field Application Specialist for Europe.InsidermediaAustralian chromatography column supplier expands UK presence at Milton ParkAustralian chromatography column supplier IonOpticks has opened its first overseas office at Milton Park business campus in Oxfordshire, taking 2,940 sq ft of laboratory and office space. The new facility will provide local stock, technical support, applications expertise and method development for customers across the UK and Europe. The company, founded in 2017 to improve liquid chromatography-mass spectrometry performance, is already growing its UK-based workforce at the site as it pursues international expansion.PrtimesThe SCIEX ZenoTOF series has evolved through platform expansion via software, integrated processing, and collaboration.SCIEX announced an evolution of its ZenoTOF series platform, including new software features and integrations. The update adds ZT Scan DIA 3.0, enhanced sensitivity modes, and integrations with PEAKS and MS-DIAL. The company aims to reduce workflow complexity and expand application areas.Business Wire BlogSCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key CollaborationsAt ASMS, SCIEX introduced platform-wide advancements for its ZenoTOF line, including SCIEX OS 5.0 software and new integrations. The updates include ZT Scan DIA 3.0 and collaborations with BSI and MS-Dial, with ZenoTOF 8600 showing 10-40% gains in low-input proteomics.The Mass Spectrometry Web PortalIon Opticks Pty Ltd.. (2/3/26). "Press Release: IonOpticks Appoints Darren Sher as Chief Commercial Officer to Lead Global Commercial Strategy".IonOpticks, a provider of liquid chromatography solutions, announced the appointment of Darren Sher as Chief Commercial Officer to lead its global commercial strategy and support international scaling. Sher brings over 25 years of experience in life science tools and clinical diagnostics, having held senior leadership roles at Revvity, Oxford Immunotec, and Siemens Healthineers. In this newly created executive role, Sher will oversee global sales, marketing, customer support, and go-to-market execution as the company expands its commercial operations worldwide.PR NewswireIonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatographyIonOpticks launched its Generation 4 Aurora Series chromatography columns, featuring 150 μm capillary flow columns and HeatSync heating accessories. The columns offer enhanced robustness, spray stability, and reproducibility for proteomics workflows. The launch aims to support drug discovery, clinical proteomics, and bioprocessing development.PR NewswireIonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatographyIonOpticks launched its 4th Generation Aurora Series chromatography columns, featuring an expanded 150 μm capillary range and HeatSync accessories for column heating. The columns offer enhanced robustness, spray stability, and reproducibility for proteomics workflows, including drug discovery and clinical proteomics.